Date(s) And Time(s):
Apr 2 2012 8:30AM - Apr 3 2012 4:15PM
Location:
DIA
800 Enterprise Rd Ste 200,
Horsham, PA 19044-3509
http://www.diahome.org/DIAHome/Education/FindEducationalOffering.aspx?pr... Course
Overview:
Risk Management Best Practices to Optimize Medicinal Product Safety
Learn proven new strategies to improve product safety, maximize patient benefits, and minimize risk.
What You Will Learn
· How the US Risk Evaluation and Mitigation Strategies (REMS) compares with the European Union Risk Management Plan (EU-RMP)
· Current state of risk communication in the United States and new initiatives designed to improve communication to promote the safe use of drugs
· Future of drug safety and risk communication
· New strategies to improve understanding of drug safety concerns among health care providers and to promote better communication to patients
· How patients comprehend and follow specific instructions
· Communicating during a crisis situation
Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.
Learning Objectives:
At the conclusion of this activity, participants should be able to:
· Describe current risk communication strategies
· Compare and contrast the US Risk Evaluation and Mitigation Strategies (REMS) and the European Union Risk Management Plan (EU-RMP)
· Explain new methods to improve the proper use of medicines to maximize patient benefit and minimize risk
· Discuss the future of drug safety and risk communication especially during a crisis situation
Target Audience:
Professionals who work in:
· Clinical safety and pharmacovigilance
· Regulatory affairs
· Medical writing
· Marketing and communications
· Clinical health care
· Drug safety surveillance
Event Code:
12434
Contact Information:
For registration questions, please contact Marilyn Ginsberg at +1-215-442-6135 or Marilyn.Ginsberg@diahome.org
For agenda details, please contact Susan Berkelbach at +1-215-442-6183 or Susan.Berkelbach@diahome.org
